Engineering multiple-domain forms of the therapeutic antibody CAMPATH-1H: effects on complement lysis. [electronic resource]
Producer: 19951212Description: 247-55 p. digitalISSN:- 0967-0149
- Alemtuzumab
- Antibodies, Monoclonal -- chemistry
- Antibodies, Monoclonal, Humanized
- Antibodies, Neoplasm
- Antigens, CD -- immunology
- Antigens, Neoplasm
- Base Sequence
- CD52 Antigen
- Cells, Cultured
- Complement Activation
- Cytotoxicity, Immunologic
- DNA Primers -- chemistry
- Dose-Response Relationship, Immunologic
- Glycoproteins
- Humans
- Immunoglobulin G -- chemistry
- Molecular Sequence Data
- Repetitive Sequences, Nucleic Acid
- Structure-Activity Relationship
- T-Lymphocytes -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.